مالطا - الإنجليزية - Medicines Authority

ferring pharmaceuticals limited - desmopressin acetate - nasal spray, solution - desmopressin acetate 0.1 mg/ml - pituitary and hypothalamic hormones and analogues

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

gedeon richter plc - estradiol - transdermal spray, solution - 1.53 mg/spray - natural and semisynthetic estrogens, plain; estradiol

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - olopatadine hydrochloride, quantity: 665 microgram/actuation (equivalent: olopatadine, qty 600 microgram/actuation); mometasone furoate monohydrate, quantity: 25.86 microgram/actuation (equivalent: mometasone furoate, qty 25 microgram/actuation) - spray, nasal - excipient ingredients: sodium chloride; hydrochloric acid; carmellose sodium; sodium hydroxide; dibasic sodium phosphate heptahydrate; dispersible cellulose; benzalkonium chloride; water for injections; polysorbate 80; disodium edetate - ryaltris is indicated for the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older.

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

jntl consumer health i (ireland) limited - nicotine - oromucosal spray, solution - drugs used in nicotine dependence; nicotine

مالطا - الإنجليزية - Medicines Authority

jntl consumer health i (ireland) limited block 5, high street, tallaght, dublin 24, , ireland - oromucosal spray - nicotine 1 µg/dose - other nervous system drugs

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - budesonide, quantity: 1.28 mg/ml - spray, suspension - excipient ingredients: potassium sorbate; polysorbate 80; disodium edetate; hydrochloric acid; purified water; dispersible cellulose; glucose - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - budesonide, quantity: 1.28 mg/ml - spray, suspension - excipient ingredients: glucose; disodium edetate; dispersible cellulose; polysorbate 80; purified water; hydrochloric acid; potassium sorbate - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - budesonide, quantity: 0.64 mg/ml - spray, suspension - excipient ingredients: potassium sorbate; glucose; dispersible cellulose; hydrochloric acid; disodium edetate; polysorbate 80; purified water - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

johnson & johnson pacific pty ltd - budesonide, quantity: 0.64 mg/ml - spray, suspension - excipient ingredients: potassium sorbate; disodium edetate; glucose; purified water; hydrochloric acid; dispersible cellulose; polysorbate 80 - rhinitis: prophylaxis and treatment of seasonal allergic rhinitis. prophylaxis and treatment of perennial allergic rhinitis. nasal polyps: treatment of nasal polyps.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - fluticasone propionate, quantity: 50 microgram/actuation; azelastine hydrochloride, quantity: 137 microgram/actuation (equivalent: azelastine, qty 125 microgram/actuation) - spray, nasal - excipient ingredients: glycerol; disodium edetate; phenethyl alcohol; purified water; carmellose sodium; microcrystalline cellulose; polysorbate 80; benzalkonium chloride - symptomatic treatment of moderate to severe allergic rhinitis and rhino-conjunctivitis in adults and children 12 years and older where use of a combination (intranasal antihistamine and glucocorticoid) is appropriate.